2.4.0.8027 - Disclosure - Note 2 - Acquisition of Assets of M.C. Healthcare Products Inc. (Details)truefalsefalse1false USDfalsefalse$c10_From1Dec2011To9Dec2011http://www.sec.gov/CIK0000718924duration2011-12-01T00:00:002011-12-09T00:00:00sharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0usdStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$c2_From31Mar2013To29Jun2013http://www.sec.gov/CIK0000718924duration2013-03-31T00:00:002013-06-29T00:00:00usdStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$c3_From1Apr2012To30Jun2012http://www.sec.gov/CIK0000718924duration2012-04-01T00:00:002012-06-30T00:00:00usdStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDfalsefalse$c4_From30Sep2012To29Jun2013http://www.sec.gov/CIK0000718924duration2012-09-30T00:00:002013-06-29T00:00:00usdStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$5false USDfalsefalse$c5_From2Oct2011To30Jun2012http://www.sec.gov/CIK0000718924duration2011-10-02T00:00:002012-06-30T00:00:00usdStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$6false USDfalsefalse$c1_AsOf29Sep2012http://www.sec.gov/CIK0000718924instant2012-09-29T00:00:000001-01-01T00:00:00usdStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 3span_Note2AcquisitionofAssetsofMCHealthcareProductsIncDetailsLineItemsspan_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Note 2 - Acquisition of Assets of M.C. Healthcare Products Inc. (Details) [Line Items]2false 4us-gaap_BusinessCombinationConsiderationTransferred1us-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse98000009800000USD$falsetruefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 30 -Paragraph 7 -URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6578-128477 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 30 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6613-128477 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e6927-128479 false2Business Combination, Consideration Transferred3false 4us-gaap_PaymentsToAcquireBusinessesGrossus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse79800007980000USD$falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585 false2Payments to Acquire Businesses, Gross4false 4span_BusinessAcquisitionPaymentForPostClosingWorkingCapitalAdjustmentspan_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse354000354000USD$falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryBusiness Acquisition Payment For Post-Closing Working Capital AdjustmentNo definition available.false2Business Acquisition Payment For Post-Closing Working Capital Adjustment5false 4us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssuedus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse100000100000falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalsexbrli:sharesItemTypesharesNumber of shares of equity interests issued or issuable to acquire entity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b)(4) -URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e6927-128479 false1Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in Shares)6false 4us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssignedus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse14410001441000USD$falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryValue of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b)(4) -URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e6927-128479 false2Business Acquisition, Equity Interest Issued or Issuable, Value Assigned7false 4us-gaap_ProceedsFromLinesOfCreditus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse65000006500000USD$falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(f)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph f -Article 4 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Financing Activities -URI http://asc.fasb.org/extlink&oid=6513228 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3255-108585 false2Proceeds from Lines of Credit8false 4us-gaap_Goodwillus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse25300002530000USD$falsefalsefalse2truefalsefalse44352534435253USD$falsefalsefalse3falsefalsefalse00falsefalsefalse4truefalsefalse44352534435253USD$falsefalsefalse5falsefalsefalse00falsefalsefalse6truefalsefalse46106154610615USD$falsefalsefalsexbrli:monetaryItemTypemonetaryAmount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=14024403&loc=d3e13816-109267 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266 false2Goodwill9false 4us-gaap_SalesRevenueNetus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2truefalsefalse1862121218621212USD$falsefalsefalse3truefalsefalse1693712916937129USD$falsefalsefalse4truefalsefalse5690462756904627USD$falsefalsefalse5truefalsefalse5836455758364557USD$falsefalsefalse6falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryTotal revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 false2Revenue, Net10false 4us-gaap_OperatingIncomeLossus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2truefalsefalse18142211814221USD$falsefalsefalse3truefalsefalse11459011145901USD$falsefalsefalse4truefalsefalse57043245704324USD$falsefalsefalse5truefalsefalse55488835548883USD$falsefalsefalse6falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThe net result for the period of deducting operating expenses from operating revenues.No definition available.false2Operating Income (Loss)11false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7false USDtruefalse$c12_From31Mar2013To29Jun2013_MCHPAcquisitionTradeNamesNonCompeteAgreementsAndCustomerRelationshipsMemberhttp://www.sec.gov/CIK0000718924duration2013-03-31T00:00:002013-06-29T00:00:00falsefalseMCHP Acquisition, Trade Names, Non-Compete Agreements and Customer Relationships [Member]us-gaap_BusinessAcquisitionAxisxbrldihttp://xbrl.org/2006/xbrldispan_MCHPAcquisitionTradeNamesNonCompeteAgreementsAndCustomerRelationshipsMemberus-gaap_BusinessAcquisitionAxisexplicitMemberusdStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0MCHP Acquisition, Trade Names, Non-Compete Agreements and Customer Relationships [Member]12true 3span_Note2AcquisitionofAssetsofMCHealthcareProductsIncDetailsLineItemsspan_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Note 2 - Acquisition of Assets of M.C. Healthcare Products Inc. (Details) [Line Items]13false 4us-gaap_SalesRevenueNetus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2truefalsefalse35000003500000USD$falsefalsefalse3truefalsefalse23000002300000USD$falsefalsefalse4truefalsefalse94000009400000USD$falsefalsefalse5truefalsefalse83000008300000USD$falsefalsefalse6falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryTotal revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 false2Revenue, Net14false 4us-gaap_OperatingIncomeLossus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2truefalsefalse211000211000USD$falsetruefalse3truefalsefalse-68000-68000USD$falsetruefalse4truefalsefalse756000756000USD$falsetruefalse5truefalsefalse10480001048000USD$falsetruefalse6falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThe net result for the period of deducting operating expenses from operating revenues.No definition available.false2Operating Income (Loss)falseNote 2 - Acquisition of Assets of M.C. Healthcare Products Inc. (Details) (USD $)NoRoundingNoRoundingUnKnownUnKnowntruefalsefalseSheethttp://www.spanamerica.com/role/Note2AcquisitionofAssetsofMCHealthcareProductsIncDetails614